Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Head and Neck Squamous Cell Cancer × sintilimab × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 10 Squamous Cell Carcinoma of Head and Neck 6 Thyroid Neoplasms 2 Salivary Gland Malignant Neoplasms 1 Precancerous Conditions 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Mouth Neoplasms 1 Locally Advanced Head and Neck Squamous Cell Carcinoma 1 Head and Neck Squamous Cell Cancer 1 Head and Neck Neoplasms 1

Interventions

Cetuximab 2 Alpelisib 2 toripalimab 1 sintilimab 1 rocakinogene sifuplasmid 1 raltitrexed 1 cabozantinib 1 VGX-3100 1 Radiotherapy, Intensity-Modulated 1 Metformin 1 MEDI0457 1 Fluorouracil 1 Cisplatin 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03975270 2019-07-18

HNSCC

ChineseAMS

Phase 2 Unknown

Head and Neck Squamous Cell Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡